Doctor profile · Federal record
Dr. LAILA ABU ZAID, M.D.
Endocrinology, Diabetes & Metabolism Physician (CMS: INTERNAL MEDICINE) · Internal Medicine Physician · Endocrinology, Diabetes & Metabolism Physician · CINCINNATI, OH
- NPI 1245588730
- Accepts Medicare
- 17 yrs in practice
- Licensed in 3 states
- Female
- Group practice
- No sanctions
Practice & contact
Operates at 2 locations .
- Primary practice
-
7575 5 MILE RD
CINCINNATI, OH 452304346
(513) 686-2663
fax (513) 686-3637 - Additional location
-
1315 S Cliff Ave Ste 3000
Sioux Falls, SD 571051061
(605) 322-7600
Credentials & registration
- NPI registered
- August 2012 — 14 yrs on file
- Profile last updated
- July 21, 2023
- Year of graduation
- 2009 — 17 yrs since
- Specialty taxonomy
- 207RE0101X — NUCC code
- State licenses (3)
- Ohio #35.147590 · Arizona #50949 · South Dakota #10721
Federal sanctions & exclusions
No sanctions, exclusions or revocations on file
Checked against OIG LEIE on NPI 1245588730. Last verified May 11, 2026.Medicare procedures · 2023
Top services delivered
Total services
383
Distinct HCPCS
7
Medicare allowed
$34,910
| HCPCS | Description | Services | Patients | Avg allowed | |
|---|---|---|---|---|---|
99214 |
Established patient office or other outpatient visit, 30-39 minutes | 156 | 138 | $94 | |
95251 |
Continuous monitoring of blood sugar level in tissue fluid using sensor under skin with interpretation and report | 76 | 60 | $33 | |
99214 |
Established patient office or other outpatient visit, 30-39 minutes | 51 | 43 | $105 | |
99204 |
New patient office or other outpatient visit, 45-59 minutes | 42 | 42 | $159 | |
99215 |
Established patient office or other outpatient visit, 40-54 minutes | 27 | 22 | $137 | |
95251 |
Continuous monitoring of blood sugar level in tissue fluid using sensor under skin with interpretation and report | 20 | 14 | $33 | |
99204 |
New patient office or other outpatient visit, 45-59 minutes | 11 | 11 | $127 |
In context: peer comparison
Among 17 peers in this city , average services per provider: 689. This provider delivers 0.6× the peer median.Open Payments
Industry payments received
All-time total
$283
Transactions
14
Manufacturers
8
| Payer (manufacturer) | Industry | Txns | Amount |
|---|---|---|---|
| Tandem Diabetes Care, Inc. | 3 | $76.65 | |
| Lilly USA, LLC | 2 | $36.27 | |
| Dexcom, Inc. | 2 | $35.41 | |
| Ascensia Diabetes Care Us Inc. | 2 | $33.10 | |
| Insulet Corporation | 2 | $32.23 | |
| SANOFI-AVENTIS U.S. LLC | 1 | $26.44 | |
| Medtronic, Inc. | 1 | $25.44 | |
| Novo Nordisk Inc | 1 | $17.13 |
By nature of payment
Medicare Part D · 2023
Top prescriptions
Total claims
1,208
Patients
399
Total drug cost
$748,058
| Drug | Type | Claims | Patients | Total cost |
|---|---|---|---|---|
| Levothyroxine Sodium | Generic | 208 | 71 | $3,300 |
| Ozempic (Semaglutide) | Brand | 199 | 52 | $277,600 |
| Lantus Solostar (Insulin Glargine,hum.Rec.Anlog) | Brand | 99 | 36 | $68,547 |
| Novolog Flexpen (Insulin Aspart) | Brand | 96 | 42 | $126,177 |
| Trulicity (Dulaglutide) | Brand | 91 | 23 | $101,932 |
| Jardiance (Empagliflozin) | Brand | 85 | 27 | $98,162 |
| Metformin Hcl Er (Metformin Hcl) | Brand | 60 | 21 | $970 |
| Atorvastatin Calcium | Generic | 58 | 19 | $683 |
| Methimazole | Generic | 54 | 17 | $746 |
| Mounjaro (Tirzepatide) | Brand | 53 | 18 | $61,471 |